Literature DB >> 26311601

Kidney Failure and Liver Allocation: Current Practices and Potential Improvements.

Varun Saxena1, Jennifer C Lai2.   

Abstract

In February 2002, the United Network for Organ Sharing implemented a system for prioritizing candidates for liver transplantation that was based on the risk of 90-day mortality as determined by the Model for End-Stage Liver Disease (MELD) score. As the MELD score is driven in part by serum creatinine as a marker of kidney function, the prevalence of kidney dysfunction and failure in patients with end-stage liver disease at the time of listing and at transplantation has steadily risen. In this review, we discuss current practices in liver transplantation in patients with kidney dysfunction focusing briefly on the decision to perform simultaneous liver-kidney transplantation. We then discuss pitfalls to the current practices of liver transplantation in patients with kidney dysfunction. We conclude by discussing potential improvements to current practices including the use of the MELD-Na score, alternatives to creatinine and creatinine-based equation for estimating kidney function, and the use of intraoperative kidney replacement therapy during liver transplantation.
Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acute kidney injury; Biomarkers; Creatinine; Liver transplant; Model for end-stage liver disease

Mesh:

Year:  2015        PMID: 26311601      PMCID: PMC4556134          DOI: 10.1053/j.ackd.2015.05.002

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  75 in total

1.  Altered permeability in the proximal tubule response to cyclic AMP.

Authors:  H R Jacobson
Journal:  Am J Physiol       Date:  1979-01

Review 2.  Estimating kidney function in adults using formulae.

Authors:  Edmund J Lamb; Charles R V Tomson; Paul J Roderick
Journal:  Ann Clin Biochem       Date:  2005-09       Impact factor: 2.057

3.  Heterogeneity in liver allocation.

Authors:  Richard Freeman
Journal:  Liver Transpl       Date:  2004-08       Impact factor: 5.799

4.  Disparities in liver transplantation in the post-model for end-stage liver disease era: are we there yet?

Authors:  Parul Dureja; Michael R Lucey
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

5.  Intra-individual variation of cystatin C and creatinine in pediatric solid organ transplant recipients.

Authors:  Ludmila Podracka; Janusz Feber; Nathalie Lepage; Guido Filler
Journal:  Pediatr Transplant       Date:  2005-02

6.  Clinical applications of biomarkers for acute kidney injury.

Authors:  Justin M Belcher; Charles L Edelstein; Chirag R Parikh
Journal:  Am J Kidney Dis       Date:  2011-03-15       Impact factor: 8.860

7.  Estimating glomerular filtration rate from serum creatinine and cystatin C.

Authors:  Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey
Journal:  N Engl J Med       Date:  2012-07-05       Impact factor: 91.245

Review 8.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

Review 9.  Cystatin C: an improved estimator of glomerular filtration rate?

Authors:  Omar F Laterza; Christopher P Price; Mitchell G Scott
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

10.  Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease.

Authors:  J F Platt; J H Ellis; J M Rubin; R M Merion; M R Lucey
Journal:  Hepatology       Date:  1994-08       Impact factor: 17.425

View more
  8 in total

Review 1.  Outcomes of liver transplantation in patients with hepatorenal syndrome.

Authors:  Rohan M Modi; Nishi Patel; Sherif N Metwally; Khalid Mumtaz
Journal:  World J Hepatol       Date:  2016-08-28

2.  Racial/Ethnic Disparities in Access and Outcomes of Simultaneous Liver-Kidney Transplant Among Liver Transplant Candidates With Renal Dysfunction in the United States.

Authors:  Su-Hsin Chang; Mei Wang; Xiaoyan Liu; Tarek Alhamad; Krista L Lentine; Mark A Schnitzler; Graham A Colditz; Yikyung Park; William C Chapman
Journal:  Transplantation       Date:  2019-08       Impact factor: 4.939

3.  Early detection of acute kidney injury in the perioperative period of liver transplant with neutrophil gelatinase-associated lipocalin.

Authors:  Camila Lima; Luciana Bertocco de Paiva Haddad; Patrícia Donado Vaz de Melo; Luiz Marcelo Malbouisson; Lilian Pires Freitas do Carmo; Luiz Augusto Carneiro D'Albuquerque; Etienne Macedo
Journal:  BMC Nephrol       Date:  2019-10-15       Impact factor: 2.388

4.  Current Challenges in the Post-Transplant Care of Liver Transplant Recipients in Germany.

Authors:  Kerstin Herzer; Martina Sterneck; Martin-Walter Welker; Silvio Nadalin; Gabriele Kirchner; Felix Braun; Christina Malessa; Adam Herber; Johann Pratschke; Karl Heinz Weiss; Elmar Jaeckel; Frank Tacke
Journal:  J Clin Med       Date:  2020-11-05       Impact factor: 4.241

5.  Modelling kidney outcomes based on MELD eras - impact of MELD score in renal endpoints after liver transplantation.

Authors:  Paulo Ricardo Gessolo Lins; Roberto Camargo Narciso; Leonardo Rolim Ferraz; Virgilio Gonçalves Pereira; Ben-Hur Ferraz-Neto; Marcio Dias De Almeida; Bento Fortunato Cardoso Dos Santos; Oscar Fernando Pavão Dos Santos; Júlio Cesar Martins Monte; Marcelino Souza Durão Júnior; Marcelo Costa Batista
Journal:  BMC Nephrol       Date:  2022-08-23       Impact factor: 2.585

6.  4-methylpyrazole protects against acetaminophen-induced acute kidney injury.

Authors:  Jephte Y Akakpo; Anup Ramachandran; Hilmi Orhan; Steven C Curry; Barry H Rumack; Hartmut Jaeschke
Journal:  Toxicol Appl Pharmacol       Date:  2020-11-04       Impact factor: 4.219

7.  Effect of transplant center volume on post-transplant survival in patients listed for simultaneous liver and kidney transplantation.

Authors:  Rohan M Modi; Dmitry Tumin; Andrew J Kruger; Eliza W Beal; Don Hayes; James Hanje; Anthony J Michaels; Kenneth Washburn; Lanla F Conteh; Sylvester M Black; Khalid Mumtaz
Journal:  World J Hepatol       Date:  2018-01-27

8.  Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region.

Authors:  Jacques Pirenne; Bart van Hoek; Andries E Braat; Ben F J Goudsmit; Hein Putter; Maarten E Tushuizen; Serge Vogelaar; Ian P J Alwayn
Journal:  Hepatology       Date:  2021-05-09       Impact factor: 17.425

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.